TGF-β1 mRNA expression in clinical breast cancer and its relationship to ER mRNA expression
- 1 January 1997
- journal article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 42 (2) , 95-101
- https://doi.org/10.1023/a:1005785421815
Abstract
Eighty nine primary breast cancers were investigated forthe expression of TGF-β1 and ER mRNA usingPCR of reverse transcribed RNA. PCR products werevalidated using Southern blots and hybridization with radiolabelledcDNA probes. TGFβ1 mRNA was found to beexpressed in 56/89 (63%) of the breast cancerswhile ER mRNA was expressed in 23/89 (26%)of the tumours. Using chi-square analysis TGF-β mRNAexpression was found to correlate significantly with ERmRNA expression (p < 0.001), in that virtuallyall tumours that expressed ER mRNA co-expressed TGFβ1.In tumours that were ER mRNA negative, TGFβ1expression was more variable. These results suggest thatduring tumour progression, ER expression is lost morefrequently than is growth factor expression.Keywords
This publication has 21 references indexed in Scilit:
- Comparison between immunocytochemical and polymerase chain reaction techniques for detection of oestrogen receptor and transforming growth factor β in breast cancerBritish Journal of Cancer, 1996
- Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression.Journal of Clinical Investigation, 1993
- Transforming growth factor β1 is implicated in the failure of tamoxifen therapy in human breast cancerBritish Journal of Cancer, 1991
- Transcripts for transforming growth factors in human breast cancer: clinical correlatesBritish Journal of Cancer, 1990
- Transforming growth factor-β: possible roles in carcinogenesisBritish Journal of Cancer, 1988
- Intron-exon structure of the human transforming growth factor-β precursor geneNucleic Acids Research, 1987
- Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cellsCell, 1987
- Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-ANature, 1986
- Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cellsNature, 1985
- New class of transforming growth factors potentiated by epidermal growth factor: isolation from non-neoplastic tissues.Proceedings of the National Academy of Sciences, 1981